Cyprotex today launches its new responsive website, www.cyprotex.com. The redesign fulfils several roles. Firstly, improved navigation; secondly, a platform where new technologies or acquisitions can be introduced more easily with maximum visibility; thirdly, a responsive website which optimises the viewing experience on different devices. The new website addresses all of these points and greatly enhances the user experience.
Commenting on the launch of the website, Dr Anthony D Baxter, Cyprotex's Chief Executive Officer, said:
“Our website is a key source of information for our customers and investors. As our portfolio of services grows, both organically and through acquisitions, it has been necessary to enhance our website to improve navigation. Mobile device usage is growing and having a responsive website which can optimise the viewing experience based on different devices is critical to keep us up-to-date with these trends. In addition to the improved functionality, sections have been introduced which are related to new testing capabilities in the personal care and chemical industries following our acquisition of CeeTox earlier this year."
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683